Sulindac NDC 42806-018

NDC codes

FDA NDC Directory

Product NDC (as listed)42806-018Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42806-0018Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
42806-018-01	42806001801	100 TABLET in 1 BOTTLE (42806-018-01)Marketed from Jan 25, 2010
42806-018-05	42806001805	500 TABLET in 1 BOTTLE (42806-018-05)Marketed from Jan 25, 2010
42806-018-10	42806001810	1000 TABLET in 1 BOTTLE (42806-018-10)Marketed from Jan 25, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulindac
Generic name (nonproprietary): sulindac
Active ingredients: Sulindac — 150 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Epic Pharma, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 072710
Marketing start: Jan 25, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 42806-018_fb793a0a-affa-4f9a-a5b4-aa1c84aa475eSPL ID fb793a0a-affa-4f9a-a5b4-aa1c84aa475eSPL set ID 96c73bd2-4577-487d-a642-bd8f91e94c3aRxCUI 198238, 198239UNII 184SNS8VUHUPC 0342806018057, 0342806011010
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442806001801 followed by a unit qualifier and the quantity

Package 42806-0018-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 20, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Sulindac is indicated for acute or long-term use in the relief of signs and symptoms of the following: 1. Osteoarthritis 2. Rheumatoid arthritis** 3. Ankylosing spondylitis 4. Acute painful shoulder (Acute subacromial bursitis/supraspinatus tendinitis) 5. Acute gouty arthritis **The safety and effectiveness of sulindac tablets USP have not been established in rheumatoid arthritis patients who are designated in the American Rh…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 072710

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 072710
Product	Strength	Form · route	Labeler	Product NDC
Sulindac	Sulindac 150 mg/1	TabletOral	PuraCap Laboratories LLC dba Blu Pharmaceuticals	24658-770